Israeli Biotech Startup Mana.bio Pushes Forward With AI-Powered Cancer Therapy Despite Recent Attacks

Israeli biotech startup Mana.bio launched an AI-powered programmable drug therapy this week despite recent attacks in the country.

The company uses AI to design nanoparticles that can deliver RNA-based therapies for diseases like cancer.

Mana.bio announced a $19.5 million seed round led by top VC firms like Andreessen Horowitz.

The CEO was set to present research papers on the technology at two upcoming conferences.

Despite the difficult circumstances, the company remains committed to pushing forward with the important work.